Revolution Medicines Inc (RVMD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -462.824 | -52.59 | -31.654 | -28.017 | -28.664 | -32.093 | -30.37 |
Return on Equity (%) | 103.047 | 55.433 | 47.435 | -68.536 | -34.735 | -38.626 | -34.751 |
Return on Invested Capital (%) | -1500.916 | -55.759 | -43.162 | -35.193 | -34.832 | -40.234 | -38.971 |
Operating Margin (%) | N/A | -206.66 | -103.777 | -252.33 | -636.54 | -704.141 | -3796.097 |
Net Profit Margin (%) | N/A | -242.103 | -123.703 | -256.795 | -636.58 | -702.954 | -3768.282 |
Book Value Per Share | 0.348 | 1.215 | 23.06 | 5.993 | 7.123 | 6.767 | 16.007 |
Earnings Per Share | -2.682 | -3.126 | -18.804 | -1.657 | -2.523 | -2.751 | -3.983 |
Cash Per Share | 0.698 | 4.456 | 5.06 | 1.566 | 1.463 | 1.785 | 6.354 |
Working Capital Per Share | 0.142 | 3.515 | 27.621 | 6.11 | 7.141 | 6.616 | 15.839 |
Operating Profit Per Share | N/A | 1.291 | 15.201 | 0.645 | 0.396 | 0.391 | 0.106 |
EBIT Per Share | -2.392 | -2.676 | -15.807 | -1.63 | -2.523 | -2.755 | -4.015 |
EBITDA Per Share | -2.392 | -2.676 | -15.807 | -1.63 | -2.523 | -2.755 | -4.015 |
Free Cash Flow Per Share | -2.652 | -3.143 | -19.033 | -1.669 | -2.492 | -2.687 | -3.968 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 13,01M | 15,62M | 3,29M | 66,6M | 74,14M | 90,41M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 90,41M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -970.887 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -970.887 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 7,39B |
Ratio cours/bénéfice | -0,07 |
Ratio prix/ventes | 2,62 |
Ratio prix/liquidités | 0,04 |
Ratio prix/valeur comptable | 0,02 |
Rendement de dividende | - |
Actions en circulation | 168,22M |
Volume moyen (1 semaine) | 1,49M |
Volume moyen (1 mois) | 2,11M |
Variation sur 52 semaines | 60,19% |
Plus haut sur 52 semaines | 62,40 |
Plus bas sur 52 semaines | 25,93 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales